← Leaderboards
Paul J Hagerman
University Of Colorado Denver
$18,917,793
Attributed
$21,157,217
Total exposure
20
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,157,217 · 20
By mechanism
R01$11,853,197 · 6
RL1$4,108,339 · 1
UL1$3,767,607 · 2
RC1$787,301 · 1
P01$358,182 · 1
P51$272,067 · 8
Top collaborators
- Frederic Louis Chedin5 shared
- Flora Tassone5 shared
- Randi J Hagerman3 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Randi J Hagerman$23,937,829
- John H Caldwell$4,138,177
- Emily Gibson$6,060,494
- Douglas Shepherd$4,476,352
Others in their field
Top investigators on “Alleles”
- Richard A Gibbs · Baylor College Of Medicine$162,061,189
- Eric S Lander · Whitehead Institute For Biomedical Res$88,310,092
- Kc Kent Lloyd · University Of California At Davis$73,526,404
- Michael A Province · Washington University$68,289,985
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard J O'Reilly · Sloan-Kettering Institute For Cancer Res$51,945,604
Research focus
AllelesCgg RepeatFragile X SyndromeFmr1 GeneMutationBaseFxtasNeurodegenerative DisordersCellsGenesMessenger RnaToxic EffectCgg Repeat ExpansionLeadMolecularElementsMental RetardationPhenotypeAffectFmr1Autistic DisorderMaleProteinsNeurons
Grant awards (62)
Genotype-Phenotype Relationships in Fragile X Families$639,626
R01 · FY2025 · HD
Genotype-Phenotype Relationships in Fragile X Families$630,394
R01 · FY2024 · HD
Genotype-Phenotype Relationships in Fragile X Families$649,652
R01 · FY2023 · HD
Epigenetic regulation of the FMR1 gene$400,299
R01 · FY2018 · GM · contact PI
Epigenetic regulation of the FMR1 gene$576,031
R01 · FY2017 · GM · contact PI
Epigenetic regulation of the FMR1 gene$384,221
R01 · FY2016 · GM · contact PI
Expression of the fragile X gene$282,138
R01 · FY2016 · HD · contact PI
Epigenetic regulation of the FMR1 gene$175,732
R01 · FY2016 · GM · contact PI
Epigenetic regulation of the FMR1 gene$383,099
R01 · FY2015 · GM · contact PI
Expression of the fragile X gene$306,087
R01 · FY2015 · HD · contact PI
Expression of the fragile X gene$305,550
R01 · FY2014 · HD · contact PI
Expression of the fragile X gene$298,686
R01 · FY2013 · HD · contact PI
Expression of the fragile X gene$314,596
R01 · FY2012 · HD · contact PI
Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)$793,447
RL1 · FY2011 · AG · contact PI
Neuro Therapeutics Research Institute (1 of 6)$764,098
UL1 · FY2011 · DE · contact PI
Expression of the Fragile X Gene$296,750
R01 · FY2011 · HD · contact PI
Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)$74,991
RL1 · FY2011 · AG · contact PI
SCREEN FOR FRAGILE X MUTATION EXPANSION IN A PRIMATE MODEL$25,210
P51 · FY2011 · RR · contact PI
Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)$798,611
RL1 · FY2010 · AG · contact PI
Neuro Therapeutics Research Institute (1 of 6)$711,892
UL1 · FY2010 · DE · contact PI
Human iPSC neuronal models for early and late phases of FXTAS neurodegeneration$393,757
RC1 · FY2010 · AG · contact PI
Expression of the Fragile X Gene$309,114
R01 · FY2010 · HD · contact PI
SCREEN FOR FRAGILE X MUTATION EXPANSION IN A PRIMATE MODEL$37,989
P51 · FY2010 · RR · contact PI
Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)$792,986
RL1 · FY2009 · AG · contact PI
Neuro Therapeutics Research Institute (1 of 6)$701,627
UL1 · FY2009 · DE · contact PI
Human iPSC neuronal models for early and late phases of FXTAS neurodegeneration$393,544
RC1 · FY2009 · AG · contact PI
Fragile X-associated Tremor/Ataxia Syndrome$372,049
R01 · FY2009 · AG · contact PI
Expression of the Fragile X Gene$312,236
R01 · FY2009 · HD · contact PI
SCREEN FOR FRAGILE X MUTATIONS IN PRIMATES$35,595
P51 · FY2009 · RR · contact PI
Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)$787,990
RL1 · FY2008 · AG · contact PI
Neuro Therapeutics Research Institute (1 of 6)$782,853
UL1 · FY2008 · DE · contact PI
Fragile X-associated Tremor/Ataxia Syndrome$360,301
R01 · FY2008 · AG · contact PI
Expression of the Fragile X Gene$312,236
R01 · FY2008 · HD · contact PI
SCREEN FOR FRAGILE X MUTATIONS IN PRIMATES$27,111
P51 · FY2008 · RR · contact PI
Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)$860,314
RL1 · FY2007 · AG · contact PI
Neuro Therapeutics Research Institute$807,137
UL1 · FY2007 · RR · contact PI
Fragile X-associated Tremor/Ataxia Syndrome$355,985
R01 · FY2007 · AG · contact PI
Expression of the Fragile X Gene$318,013
R01 · FY2007 · HD · contact PI
Expression of the Fragile X Gene$151,708
R01 · FY2007 · HD · contact PI
SCREEN FOR FRAGILE X MUTATIONS IN PRIMATES$24,607
P51 · FY2007 · RR · contact PI
Fragile X-associated Tremor/Ataxia Syndrome$354,260
R01 · FY2006 · AG · contact PI
SCREEN FOR FRAGILE X MUTATIONS IN PRIMATES$24,804
P51 · FY2006 · RR · contact PI
Fragile X-associated Tremor/Ataxia Syndrome$363,733
R01 · FY2005 · AG
Neurological Phenotype in FMR1 Premutation Carriers$281,664
R01 · FY2005 · NS
Expression of the Fragile X Gene$267,300
R01 · FY2005 · HD
SCREEN FOR FRAGILE X MUTATIONS IN PRIMATES$27,726
P51 · FY2005 · RR
Neurological Phenotype in FMR1 Premutation Carriers$283,920
R01 · FY2004 · NS
Expression of the Fragile X Gene$267,300
R01 · FY2004 · HD
SCREEN FOR FRAGILE X MUTATIONS IN PRIMATES$68,007
P51 · FY2004 · RR
NEUROLOGICAL PHENOTYPE IN FMR1 PREMUTATION CARRIERS$10,524
M01 · FY2004 · RR
Neurological Phenotype in FMR1 Premutation Carriers$286,175
R01 · FY2003 · NS
Expression of the Fragile X Gene$267,300
R01 · FY2003 · HD
SCREEN FOR FRAGILE X MUTATIONS IN PRIMATES$1,018
P51 · FY2003 · RR
Neurological Phenotype in FMR1 Premutation Carriers$309,981
R01 · FY2002 · NS
Expression of the Fragile X Gene$267,075
R01 · FY2002 · HD
PROTEIN NUCLEIC ACID INTERACTIONS$264,728
R01 · FY2002 · GM
Core--molecular biomarkers facility$179,091
P01 · FY2002 · ES
Core--molecular biomarkers facility$179,091
P01 · FY2002 · ES
PROTEIN NUCLEIC ACID INTERACTIONS$256,312
R01 · FY2001 · GM
Core--molecular biomarkers facility$0
P01 · FY2001 · ES
PROTEIN NUCLEIC ACID INTERACTIONS$191,108
R01 · FY2000 · GM
PROTEIN NUCLEIC ACID INTERACTIONS$57,838
R01 · FY2000 · GM